A Preliminary Study of Prophylactic Fentanyl Buccal Tablets (FBT) for Exercise Induced Breakthrough Dyspnea

Trial Profile

A Preliminary Study of Prophylactic Fentanyl Buccal Tablets (FBT) for Exercise Induced Breakthrough Dyspnea

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2017

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Dyspnoea
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2017 Results analysing the effect of prophylactic fentanyl buccal tablet (FBT) on exertional dyspnea in patients with cancer, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
    • 31 May 2017 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
    • 27 May 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top